Global Experts Seek a Shared Definition for Social Prescribing
Social prescribing has moved from a niche concept to a global clinical and policy conversation, but its rapid spread has also exposed a basic problem: the term does not mean exactly the same thing in every setting. In response, a Delphi study brought together 48 experts from 26 countries to establish agreement on a definition of social prescribing. The exercise was not simply academic taxonomy. In a field now used across primary care, community health, and health-system planning, inconsistent language can distort evaluation, complicate referrals, and make it harder to compare programs across jurisdictions.
The collective commentary around this work treats the Delphi process as a necessary attempt to build common ground across countries where health systems, referral pathways, and community resources differ widely. Social prescribing is often invoked as a bridge between medical care and non-medical supports, but that bridge only works if clinicians, researchers, commissioners, and community partners are talking about the same intervention. Without shared terminology, a referral to a community asset in one country may look very different from a formalized link worker model in another. The definition matters because it shapes what counts as social prescribing, what outcomes are measured, and which services are eligible for support.
Consensus methods are useful when a field is expanding faster than its language. The Delphi approach is designed to draw structured agreement from a panel of experienced stakeholders, and in this case the panel included experts from a broad international spread. The goal was not to flatten local variation or erase context. It was to define the core elements that make an intervention recognizably social prescribing, even when the surrounding health system looks different from one country to the next.
One sentence captures the urgency of the effort: a field cannot scale cleanly when its own definition is unstable.
Why Definition Shapes Practice at the Bedside
For clinicians, definitional clarity is more than a research concern. Referrals into social prescribing pathways often arise when medical treatment alone does not address loneliness, stress, inactivity, housing strain, financial pressure, or gaps in community connection. Those are not trivial add-ons to clinical care; they can influence symptom burden, adherence, and a patient’s ability to engage with treatment. If a provider cannot distinguish social prescribing from generic signposting, volunteer navigation, or broad community referral, the referral process becomes inconsistent and its outcomes become difficult to interpret.
A shared definition also affects implementation fidelity. Health systems trying to adopt social prescribing need to know which components are essential and which can vary. Some programs may center on primary care referrals; others may rely on multidisciplinary teams or community link workers. Some may focus on individual well-being, while others emphasize population health or service integration. A consensus definition gives researchers and health leaders a common reference point when they test these models, compare outcomes, or decide whether a service has been delivered as intended.
The commentary positions the Delphi output as a platform rather than a final verdict. That distinction is important. A definition can create order without ending debate, especially in a field that spans clinical medicine, public health, social care, and community development. The immediate value lies in reducing ambiguity. The longer-term value lies in making future evidence more comparable, because studies that use the same core term can be interpreted against a shared framework rather than a patchwork of local meanings.
Cross-National Agreement, Local Variation, and the Limits of Uniformity
The international composition of the Delphi panel is one of the clearest strengths of the work. Forty-eight experts across 26 countries bring perspective from settings where social prescribing may be formalized, emerging, or still loosely organized. That breadth matters because a definition built only within one health system can become too narrow to travel. At the same time, a definition that tries to accommodate every possible local model risks becoming so broad that it loses practical meaning.
This tension sits at the center of the commentary. Social prescribing must be general enough to be useful across systems, but specific enough to distinguish it from neighboring practices such as referral to social services, health coaching, or standard community advice. The relevance of the Delphi study lies in its attempt to identify the shared clinical and operational core while leaving room for contextual adaptation. In real-world use, the model has to survive different funding structures, workforce arrangements, and community resource levels. A definition that ignores those realities will fail at implementation.
The biological and behavioral rationale for social prescribing remains tied to the connection between social conditions and health outcomes. Patients often present with medical symptoms shaped by isolation, inactivity, poor social support, or chronic stress. A referral pathway that recognizes those drivers can extend care beyond the prescription pad, connecting people to activities and supports that may influence functioning and quality of life. The mechanism is indirect, but it is clinically relevant: reducing social strain can change how patients experience illness and how well they can participate in care.
What This Consensus Can and Cannot Do
The commentary asks readers to think carefully about how consensus work is used. A definition can stabilize terminology, but it does not by itself prove effectiveness, determine which patients benefit most, or resolve implementation barriers. Those questions still require empirical study. It also does not settle whether every health system should adopt the same delivery model. Some settings may need highly structured pathways; others may rely on more flexible community-based approaches.
Still, consensus has practical value. It can improve the quality of future trials, sharpen inclusion criteria, and reduce confusion in policy documents. It can also help clinicians communicate more precisely when explaining referrals to patients. If social prescribing is to remain credible in routine care, the field needs terms that can survive translation across countries and disciplines without losing their core meaning.
A second sentence captures the clinical consequence plainly: without a shared definition, evidence accumulates in fragments.
The Delphi study does not close the debate over social prescribing; it gives that debate a more stable vocabulary. The next challenge is whether researchers, health systems, and community partners use that vocabulary consistently enough to make future evaluations comparable across contexts, rather than letting a popular term continue to mean too many different things at once.